Cargando…

Structure–Affinity Relationships and Structure–Kinetics Relationships of Pyrido[2,1-f]purine-2,4-dione Derivatives as Human Adenosine A(3) Receptor Antagonists

[Image: see text] We expanded on a series of pyrido[2,1-f]purine-2,4-dione derivatives as human adenosine A(3) receptor (hA(3)R) antagonists to determine their kinetic profiles and affinities. Many compounds showed high affinities and a diverse range of kinetic profiles. We found hA(3)R antagonists...

Descripción completa

Detalles Bibliográficos
Autores principales: Xia, Lizi, Burger, Wessel A. C., van Veldhoven, Jacobus P. D., Kuiper, Boaz J., van Duijl, Tirsa T., Lenselink, Eelke B., Paasman, Ellen, Heitman, Laura H., IJzerman, Adriaan P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2017
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5601358/
https://www.ncbi.nlm.nih.gov/pubmed/28806076
http://dx.doi.org/10.1021/acs.jmedchem.7b00950
_version_ 1783264375114563584
author Xia, Lizi
Burger, Wessel A. C.
van Veldhoven, Jacobus P. D.
Kuiper, Boaz J.
van Duijl, Tirsa T.
Lenselink, Eelke B.
Paasman, Ellen
Heitman, Laura H.
IJzerman, Adriaan P.
author_facet Xia, Lizi
Burger, Wessel A. C.
van Veldhoven, Jacobus P. D.
Kuiper, Boaz J.
van Duijl, Tirsa T.
Lenselink, Eelke B.
Paasman, Ellen
Heitman, Laura H.
IJzerman, Adriaan P.
author_sort Xia, Lizi
collection PubMed
description [Image: see text] We expanded on a series of pyrido[2,1-f]purine-2,4-dione derivatives as human adenosine A(3) receptor (hA(3)R) antagonists to determine their kinetic profiles and affinities. Many compounds showed high affinities and a diverse range of kinetic profiles. We found hA(3)R antagonists with very short residence time (RT) at the receptor (2.2 min for 5) and much longer RTs (e.g., 376 min for 27 or 391 min for 31). Two representative antagonists (5 and 27) were tested in [(35)S]GTPγS binding assays, and their RTs appeared correlated to their (in)surmountable antagonism. From a k(on)–k(off)–K(D) kinetic map, we divided the antagonists into three subgroups, providing a possible direction for the further development of hA(3)R antagonists. Additionally, we performed a computational modeling study that sheds light on the crucial receptor interactions, dictating the compounds’ binding kinetics. Knowledge of target binding kinetics appears useful for developing and triaging new hA(3)R antagonists in the early phase of drug discovery.
format Online
Article
Text
id pubmed-5601358
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher American Chemical Society
record_format MEDLINE/PubMed
spelling pubmed-56013582017-09-19 Structure–Affinity Relationships and Structure–Kinetics Relationships of Pyrido[2,1-f]purine-2,4-dione Derivatives as Human Adenosine A(3) Receptor Antagonists Xia, Lizi Burger, Wessel A. C. van Veldhoven, Jacobus P. D. Kuiper, Boaz J. van Duijl, Tirsa T. Lenselink, Eelke B. Paasman, Ellen Heitman, Laura H. IJzerman, Adriaan P. J Med Chem [Image: see text] We expanded on a series of pyrido[2,1-f]purine-2,4-dione derivatives as human adenosine A(3) receptor (hA(3)R) antagonists to determine their kinetic profiles and affinities. Many compounds showed high affinities and a diverse range of kinetic profiles. We found hA(3)R antagonists with very short residence time (RT) at the receptor (2.2 min for 5) and much longer RTs (e.g., 376 min for 27 or 391 min for 31). Two representative antagonists (5 and 27) were tested in [(35)S]GTPγS binding assays, and their RTs appeared correlated to their (in)surmountable antagonism. From a k(on)–k(off)–K(D) kinetic map, we divided the antagonists into three subgroups, providing a possible direction for the further development of hA(3)R antagonists. Additionally, we performed a computational modeling study that sheds light on the crucial receptor interactions, dictating the compounds’ binding kinetics. Knowledge of target binding kinetics appears useful for developing and triaging new hA(3)R antagonists in the early phase of drug discovery. American Chemical Society 2017-08-14 2017-09-14 /pmc/articles/PMC5601358/ /pubmed/28806076 http://dx.doi.org/10.1021/acs.jmedchem.7b00950 Text en Copyright © 2017 American Chemical Society This is an open access article published under a Creative Commons Non-Commercial No Derivative Works (CC-BY-NC-ND) Attribution License (http://pubs.acs.org/page/policy/authorchoice_ccbyncnd_termsofuse.html) , which permits copying and redistribution of the article, and creation of adaptations, all for non-commercial purposes.
spellingShingle Xia, Lizi
Burger, Wessel A. C.
van Veldhoven, Jacobus P. D.
Kuiper, Boaz J.
van Duijl, Tirsa T.
Lenselink, Eelke B.
Paasman, Ellen
Heitman, Laura H.
IJzerman, Adriaan P.
Structure–Affinity Relationships and Structure–Kinetics Relationships of Pyrido[2,1-f]purine-2,4-dione Derivatives as Human Adenosine A(3) Receptor Antagonists
title Structure–Affinity Relationships and Structure–Kinetics Relationships of Pyrido[2,1-f]purine-2,4-dione Derivatives as Human Adenosine A(3) Receptor Antagonists
title_full Structure–Affinity Relationships and Structure–Kinetics Relationships of Pyrido[2,1-f]purine-2,4-dione Derivatives as Human Adenosine A(3) Receptor Antagonists
title_fullStr Structure–Affinity Relationships and Structure–Kinetics Relationships of Pyrido[2,1-f]purine-2,4-dione Derivatives as Human Adenosine A(3) Receptor Antagonists
title_full_unstemmed Structure–Affinity Relationships and Structure–Kinetics Relationships of Pyrido[2,1-f]purine-2,4-dione Derivatives as Human Adenosine A(3) Receptor Antagonists
title_short Structure–Affinity Relationships and Structure–Kinetics Relationships of Pyrido[2,1-f]purine-2,4-dione Derivatives as Human Adenosine A(3) Receptor Antagonists
title_sort structure–affinity relationships and structure–kinetics relationships of pyrido[2,1-f]purine-2,4-dione derivatives as human adenosine a(3) receptor antagonists
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5601358/
https://www.ncbi.nlm.nih.gov/pubmed/28806076
http://dx.doi.org/10.1021/acs.jmedchem.7b00950
work_keys_str_mv AT xializi structureaffinityrelationshipsandstructurekineticsrelationshipsofpyrido21fpurine24dionederivativesashumanadenosinea3receptorantagonists
AT burgerwesselac structureaffinityrelationshipsandstructurekineticsrelationshipsofpyrido21fpurine24dionederivativesashumanadenosinea3receptorantagonists
AT vanveldhovenjacobuspd structureaffinityrelationshipsandstructurekineticsrelationshipsofpyrido21fpurine24dionederivativesashumanadenosinea3receptorantagonists
AT kuiperboazj structureaffinityrelationshipsandstructurekineticsrelationshipsofpyrido21fpurine24dionederivativesashumanadenosinea3receptorantagonists
AT vanduijltirsat structureaffinityrelationshipsandstructurekineticsrelationshipsofpyrido21fpurine24dionederivativesashumanadenosinea3receptorantagonists
AT lenselinkeelkeb structureaffinityrelationshipsandstructurekineticsrelationshipsofpyrido21fpurine24dionederivativesashumanadenosinea3receptorantagonists
AT paasmanellen structureaffinityrelationshipsandstructurekineticsrelationshipsofpyrido21fpurine24dionederivativesashumanadenosinea3receptorantagonists
AT heitmanlaurah structureaffinityrelationshipsandstructurekineticsrelationshipsofpyrido21fpurine24dionederivativesashumanadenosinea3receptorantagonists
AT ijzermanadriaanp structureaffinityrelationshipsandstructurekineticsrelationshipsofpyrido21fpurine24dionederivativesashumanadenosinea3receptorantagonists